[1]
“Short-term safety and beneficial effects of hydroxyurea therapy in children with sickle cell disease”, Indian J Child Health, vol. 7, no. 1, pp. 29–32, Jan. 2020, doi: 10.32677/IJCH.2020.v07.i01.008.